Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients.

DNA methylation is an epigenetic mark that is influenced by environmental factors and is associated with changes to gene expression and phenotypes. It may link environmental exposures to disease etiology or indicate important gene pathways involved in disease pathogenesis. We identified genomic regi...

Full description

Bibliographic Details
Main Authors: Brooke Rhead, Ina S Brorson, Tone Berge, Cameron Adams, Hong Quach, Stine Marit Moen, Pål Berg-Hansen, Elisabeth Gulowsen Celius, Dipen P Sangurdekar, Paola G Bronson, Rodney A Lea, Sean Burnard, Vicki E Maltby, Rodney J Scott, Jeannette Lechner-Scott, Hanne F Harbo, Steffan D Bos, Lisa F Barcellos
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6209300?pdf=render
_version_ 1818282306556657664
author Brooke Rhead
Ina S Brorson
Tone Berge
Cameron Adams
Hong Quach
Stine Marit Moen
Pål Berg-Hansen
Elisabeth Gulowsen Celius
Dipen P Sangurdekar
Paola G Bronson
Rodney A Lea
Sean Burnard
Vicki E Maltby
Rodney J Scott
Jeannette Lechner-Scott
Hanne F Harbo
Steffan D Bos
Lisa F Barcellos
author_facet Brooke Rhead
Ina S Brorson
Tone Berge
Cameron Adams
Hong Quach
Stine Marit Moen
Pål Berg-Hansen
Elisabeth Gulowsen Celius
Dipen P Sangurdekar
Paola G Bronson
Rodney A Lea
Sean Burnard
Vicki E Maltby
Rodney J Scott
Jeannette Lechner-Scott
Hanne F Harbo
Steffan D Bos
Lisa F Barcellos
author_sort Brooke Rhead
collection DOAJ
description DNA methylation is an epigenetic mark that is influenced by environmental factors and is associated with changes to gene expression and phenotypes. It may link environmental exposures to disease etiology or indicate important gene pathways involved in disease pathogenesis. We identified genomic regions that are differentially methylated in T cells of patients with relapsing remitting multiple sclerosis (MS) compared to healthy controls. DNA methylation was assessed at 450,000 genomic sites in CD4+ and CD8+ T cells purified from peripheral blood of 94 women with MS and 94 healthy women, and differentially methylated regions were identified using bumphunter. Differential DNA methylation was observed near four loci: MOG/ZFP57, HLA-DRB1, NINJ2/LOC100049716, and SLFN12. Increased methylation of the first exon of the SLFN12 gene was observed in both T cell subtypes and remained present after restricting analyses to samples from patients who had never been on treatment or had been off treatment for more than 2.5 years. Genes near the regions of differential methylation in T cells were assessed for differential expression in whole blood samples from a separate population of 1,329 women with MS and 97 healthy women. Gene expression of HLA-DRB1, NINJ2, and SLFN12 was observed to be decreased in whole blood in MS patients compared to controls. We conclude that T cells from MS patients display regions of differential DNA methylation compared to controls, and corresponding gene expression differences are observed in whole blood. Two of the genes that showed both methylation and expression differences, NINJ2 and SLFN12, have not previously been implicated in MS. SLFN12 is a particularly compelling target of further research, as this gene is known to be down-regulated during T cell activation and up-regulated by type I interferons (IFNs), which are used to treat MS.
first_indexed 2024-12-13T00:18:55Z
format Article
id doaj.art-f7193d155a0b49f58deed8a0dedea550
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T00:18:55Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-f7193d155a0b49f58deed8a0dedea5502022-12-22T00:05:41ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-011310e020651110.1371/journal.pone.0206511Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients.Brooke RheadIna S BrorsonTone BergeCameron AdamsHong QuachStine Marit MoenPål Berg-HansenElisabeth Gulowsen CeliusDipen P SangurdekarPaola G BronsonRodney A LeaSean BurnardVicki E MaltbyRodney J ScottJeannette Lechner-ScottHanne F HarboSteffan D BosLisa F BarcellosDNA methylation is an epigenetic mark that is influenced by environmental factors and is associated with changes to gene expression and phenotypes. It may link environmental exposures to disease etiology or indicate important gene pathways involved in disease pathogenesis. We identified genomic regions that are differentially methylated in T cells of patients with relapsing remitting multiple sclerosis (MS) compared to healthy controls. DNA methylation was assessed at 450,000 genomic sites in CD4+ and CD8+ T cells purified from peripheral blood of 94 women with MS and 94 healthy women, and differentially methylated regions were identified using bumphunter. Differential DNA methylation was observed near four loci: MOG/ZFP57, HLA-DRB1, NINJ2/LOC100049716, and SLFN12. Increased methylation of the first exon of the SLFN12 gene was observed in both T cell subtypes and remained present after restricting analyses to samples from patients who had never been on treatment or had been off treatment for more than 2.5 years. Genes near the regions of differential methylation in T cells were assessed for differential expression in whole blood samples from a separate population of 1,329 women with MS and 97 healthy women. Gene expression of HLA-DRB1, NINJ2, and SLFN12 was observed to be decreased in whole blood in MS patients compared to controls. We conclude that T cells from MS patients display regions of differential DNA methylation compared to controls, and corresponding gene expression differences are observed in whole blood. Two of the genes that showed both methylation and expression differences, NINJ2 and SLFN12, have not previously been implicated in MS. SLFN12 is a particularly compelling target of further research, as this gene is known to be down-regulated during T cell activation and up-regulated by type I interferons (IFNs), which are used to treat MS.http://europepmc.org/articles/PMC6209300?pdf=render
spellingShingle Brooke Rhead
Ina S Brorson
Tone Berge
Cameron Adams
Hong Quach
Stine Marit Moen
Pål Berg-Hansen
Elisabeth Gulowsen Celius
Dipen P Sangurdekar
Paola G Bronson
Rodney A Lea
Sean Burnard
Vicki E Maltby
Rodney J Scott
Jeannette Lechner-Scott
Hanne F Harbo
Steffan D Bos
Lisa F Barcellos
Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients.
PLoS ONE
title Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients.
title_full Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients.
title_fullStr Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients.
title_full_unstemmed Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients.
title_short Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients.
title_sort increased dna methylation of slfn12 in cd4 and cd8 t cells from multiple sclerosis patients
url http://europepmc.org/articles/PMC6209300?pdf=render
work_keys_str_mv AT brookerhead increaseddnamethylationofslfn12incd4andcd8tcellsfrommultiplesclerosispatients
AT inasbrorson increaseddnamethylationofslfn12incd4andcd8tcellsfrommultiplesclerosispatients
AT toneberge increaseddnamethylationofslfn12incd4andcd8tcellsfrommultiplesclerosispatients
AT cameronadams increaseddnamethylationofslfn12incd4andcd8tcellsfrommultiplesclerosispatients
AT hongquach increaseddnamethylationofslfn12incd4andcd8tcellsfrommultiplesclerosispatients
AT stinemaritmoen increaseddnamethylationofslfn12incd4andcd8tcellsfrommultiplesclerosispatients
AT palberghansen increaseddnamethylationofslfn12incd4andcd8tcellsfrommultiplesclerosispatients
AT elisabethgulowsencelius increaseddnamethylationofslfn12incd4andcd8tcellsfrommultiplesclerosispatients
AT dipenpsangurdekar increaseddnamethylationofslfn12incd4andcd8tcellsfrommultiplesclerosispatients
AT paolagbronson increaseddnamethylationofslfn12incd4andcd8tcellsfrommultiplesclerosispatients
AT rodneyalea increaseddnamethylationofslfn12incd4andcd8tcellsfrommultiplesclerosispatients
AT seanburnard increaseddnamethylationofslfn12incd4andcd8tcellsfrommultiplesclerosispatients
AT vickiemaltby increaseddnamethylationofslfn12incd4andcd8tcellsfrommultiplesclerosispatients
AT rodneyjscott increaseddnamethylationofslfn12incd4andcd8tcellsfrommultiplesclerosispatients
AT jeannettelechnerscott increaseddnamethylationofslfn12incd4andcd8tcellsfrommultiplesclerosispatients
AT hannefharbo increaseddnamethylationofslfn12incd4andcd8tcellsfrommultiplesclerosispatients
AT steffandbos increaseddnamethylationofslfn12incd4andcd8tcellsfrommultiplesclerosispatients
AT lisafbarcellos increaseddnamethylationofslfn12incd4andcd8tcellsfrommultiplesclerosispatients